Establishing a fair market value for a clinical trial that both sponsors and sites can agree on often is easier said than done. There is little or no consensus on the “fair” price to be paid for clinical trial services.…
Lack of Training Compromises Trial Results, Expert Says
At its very core, a clinical trial is a measurement system. But unlike other fields that rely on measurement and data reporting, the clinical trials industry has not focused enough on training for everyone involved, from the investigators all the…
Navitas Life Sciences Announces Acquisition of KAI CRO
Navitas Life Sciences, a TAKE Solutions Enterprise announced the acquisition of US based niche full service CRO and health research company, KAI Research Inc. KAI Research brings offerings in three key areas – Clinical Trial Management, Clinical Research Consultation, and…
Biotech Companies Provide High Median Salaries, Analysis Shows
For young people looking to find a career path, the pharmaceutical industry is a good one to go into, especially if salary is a major concern. A recent analysis from the Wall Street Journal highlighted some of the best-paying jobs…
Report Highlights Positive Progress on Global Access to Medications
Pharma and biotech companies have been developing cutting-edge treatments and medications for a myriad of diseases but, for some patients, getting those medications has become a herculean task. In the United States, pricing has become a significant issue for many…
Nektar Forms New Subsidiary in Anticipation of Opioid Medication Approval
With a potential approval of an opioid molecule awaiting regulatory review, Nektar Therapeuticsannounced the launch of a new subsidiary, Inheris Biopharma, Inc., which will be responsible for the launch and commercialization of the opioid. NKTR-181 is a novel, first-in-class, investigational…
Risk-Based Monitoring Should Be Best Practice, ACRO Tells FDA
The Association of Clinical Research Organizations (ACRO) is urging the FDA to place even more emphasis on risk-based monitoring (RBM) of clinical trials, saying a recent study of its members showed a 16 percent reduction in major findings in audits…
Verily ( A Google company), Pharma Join Together To Develop Clinical Research Programs With Project Baseline
Today Verily, an Alphabet company, announced strategic alliances with Novartis, Otsuka, Pfizer, and Sanofi to develop digitally innovative, patient-centered clinical research programs using Project Baseline’s evidence generation platform and tools. The Baseline Platform is designed to engage more patients and…
Relationships, Not Money, Key to Avoiding Conflict of Interest
Although there are plenty of horror stories about bad actors who manipulate investigations for their own financial gain, conflicts of interest can also be subtle and even unintentional. And those potential conflicts aren’t always captured when reporting requirements are…
China isn’t yet ready to conduct clinical trials for the pharma industry
China, with its huge population and its position as the second-largest pharmaceutical market in the world, should be poised to become a world leader in clinical trials for new drugs and devices. But it isn’t quite ready for that. Nearly…
